Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development
Shigeyuki Chaki, Mai Watanabe
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1451-1462
Closed Access | Times Cited: 16

Showing 16 citing articles:

Targeting metaplasticity mechanisms to promote sustained antidepressant actions
Kyle A. Brown, Todd D. Gould
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1114-1127
Open Access | Times Cited: 18
Novel insight into astrocyte-mediated gliotransmission modulates the synaptic plasticity in major depressive disorder
Lan Lei, Yufei Wang, Cong-Ya Chen, et al.
Life Sciences (2024) Vol. 355, pp. 122988-122988
Closed Access | Times Cited: 11
Clinical pharmacological innovation in the treatment of depression
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 349-362
Closed Access | Times Cited: 14
Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine
Daniele Cavaleri, Ilaria Riboldi, Cristina Crocamo, et al.
Neuroscience Letters (2024) Vol. 831, pp. 137791-137791
Open Access | Times Cited: 5
Design, Synthesis, Pharmacology, and In Silico Studies of (1S,2S,3S)-2-((S)-Amino(carboxy)methyl)-3-(carboxymethyl)cyclopropane-1-carboxylic Acid (LBG30300): A Picomolar Potency Subtype-Selective mGlu2 Receptor Agonist
Na Liu, Floriane Eshak, Fanny Malhaire, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1314-1326
Closed Access | Times Cited: 4
6-Aryl Isoindolin-1-ones: Novel mGluR2 Negative Allosteric Modulators
Yinlong Li, Steven H. Liang
ACS Medicinal Chemistry Letters (2025)
Closed Access
Is there a continued need for behavioral pharmacology in the discovery and development of medicines?
Jeffrey M. Witkin, Jodi L. Smith, Daniel P. Radin
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103571-103571
Closed Access
Multi‐Omics Analysis Reveals Disturbances of Purine Metabolism and Glutamate Metabolism in the Hippocampus of Lipopolysaccharide‐Induced Mouse Model of Depression
Wenwen Li, Rui Xiao, Xueyi Chen, et al.
Brain and Behavior (2025) Vol. 15, Iss. 5
Open Access
Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression
Florian Freudenberg, Christine Reif-Leonhard, Andreas Reif
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 2
Synthesis and pharmacological characterization of conformationally restricted 2-amino-Adipic acid analogs and carboxycyclopropyl glycines as selective metabotropic glutamate 2 receptor agonists
Markus Staudt, Na Liu, Fanny Malhaire, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116157-116157
Open Access | Times Cited: 1
Metabotropic Glutamate Receptor 2 Expression Is Chronically Elevated in Male Rats With Post-Traumatic Stress Disorder Related Behavioral Traits Following Repetitive Low-Level Blast Exposure
Rita De Gasperi, Miguel A. Gama Sosa, Georgina Perez Garcia, et al.
Journal of Neurotrauma (2023) Vol. 41, Iss. 5-6, pp. 714-733
Closed Access | Times Cited: 3
New treatment strategies for mental health
Kenji Hashimoto, Andrea Schmitt
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1399-1401
Open Access | Times Cited: 1
Role of mGlu receptors in psychiatric disorders – Recent advances
Andrzej Pilc, Shigeyuki Chaki
Pharmacology Biochemistry and Behavior (2023) Vol. 232, pp. 173639-173639
Open Access | Times Cited: 1
Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
Barbara Chruścicka‐Smaga, Agata Machaczka, Bernadeta Szewczyk, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1341-1349
Open Access | Times Cited: 1
Astrocytes mGluR3 deficiency and inhibition restores depressive-like behaviors in CSDS mice
Mingming Chen, Yatao Liu, Lingling Shi, et al.
Research Square (Research Square) (2024)
Open Access
Discovery of 6,7-Dihydropyrazolo[1,5-a]pyrazin-4(5H)-one Derivatives as mGluR2 Negative Allosteric Modulators with In Vivo Activity in a Rodent’s Model of Cognition
Sergio A. Alonso de Diego, María Lourdes Linares, Aránzazu García Molina, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 15569-15585
Closed Access
Page 1

Scroll to top